Ruixiang Xia

Prof. Ruixiang Xia


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 September 2016 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
JSJiangluqi Song
Jiangluqi Song
CMChao Ma
Chao Ma
WZWenzhe Zhang
Wenzhe Zhang
XLXiaodong Li
Xiaodong Li
WZWenting Zhang
Wenting Zhang
XXXiaoliang Xu
Xiaoliang Xu

1 September 2018 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
LXLiang Xia
Liang Xia
LWLinlin Wu
Linlin Wu
JBJing Bao
Jing Bao
QLQingsheng Li
Qingsheng Li
XCXiaowen Chen
Xiaowen Chen
RXRuixiang Xia
Ruixiang Xia

5 October 2011 in American Journal of Hematology
Verified
Journal Article
Open access
PDF file
QZQingshu Zeng
Qingshu Zeng
LZLingyan Zhu
Lingyan Zhu
LTLili Tao
Lili Tao
JBJing Bao
Jing Bao
MYMingzhen Yang
Mingzhen Yang
HNHeyu Ni
Heyu Ni
Immune thrombocytopenia (ITP) is characterized by platelet clearance mediated primarily by autoantibodies against the platelet GPIIbIIIa and/or GPIbα. Steroid therapy is a first‐line treatment for ITP. However, some patients are refractory to this therapy and currently no method can predict which patients will respond. To evaluate whether steroids are equally efficacious in treating patients with ITP caused by anti‐GPIIbIIIa versus anti‐GPIbα antibodies, we performed a retrospective study on 176 newly diagnosed patients with acute ITP who had severe bleeding symptoms and were admitted as resident patients to the hospital. The patients were treated first with intravenous administration of high‐dose dexamethasone (DXM), followed by oral administration of prednisone. Response to therapy was observed in a majority of patients with antibodies specific for GPIIbIIIa (31/43) or without detectable antibodies against either GPIIbIIIa or GPIbα (36/45). In contrast, the steroid response was significantly lower in patients with anti‐GPIbα antibodies (9/34) or with antibodies against both GPIbα and GPIIbIIIa (16/54). The preliminary findings of this study suggest that in future prospective clinical trials including corticosteroids, the anti‐GPIbα, and ‐GPIIbIIIa status should be assessed in order to test its potential relevance in deciding future treatments. © Wiley Periodicals, Inc.

6 February 2015 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
TJTongtong Jiang
Tongtong Jiang
JSJiangluqi Song
Jiangluqi Song
HWHuijie Wang
Huijie Wang
XYXuecheng Ye
Xuecheng Ye
HWHao Wang
Hao Wang
XXXiaoliang Xu
Xiaoliang Xu
Cu doped Zn–In–S/ZnS QDs were synthesized for labeling the cytoplasm and their multiple peak emission mechanisms were proposed.

16 January 2015 in Inorganic Chemistry
Verified
Journal Article
Closed access
JSJiangluqi Song
Jiangluqi Song
TJTongtong Jiang
Tongtong Jiang
TGTianyi Guo
Tianyi Guo
LLLing Liu
Ling Liu
HWHuijie Wang
Huijie Wang
XXXiaoliang Xu
Xiaoliang Xu

18 March 2019 in Nanoscale
Verified
Journal Article
Closed access
PDF file
AAAsad Ali
Asad Ali
FMFarhana Akbar Mangrio
Farhana Akbar Mangrio
XCXiaolin Chen
Xiaolin Chen
YDYiwen Dai
Yiwen Dai
KCKui Chen
Kui Chen
LZLixin Zhu
Lixin Zhu
In this work, we prepared ultrathin MoS 2 nanosheets with exposed active edge sites and high electric conductivity that can sufficiently absorb light in the visible region to enable solar energy conversion.